Bradley, Allan
T-Therapeutics,
United Kingdom
2025 Rank: 47536
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 1084 out of 157999 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47536 | 49061 |
| Total Cites | 1900 | 2003 |
| H-index | 20 | 22 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 37 | 38 |
| Number of Single+First+Last Authored Papers | 159 | 159 |
| Total Cites to Single+First+Last Authored Papers | 781 | 799 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1679 | 1749 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
5.14%
|
|
Bradley, Allan
Wellcome Sanger Institute,
United Kingdom
2024 Rank: 39277
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 982 out of 149337 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39277 | 44464 |
| Total Cites | 2099 | 2246 |
| H-index | 20 | 20 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 40 | 40 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 869 | 899 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1864 | 1947 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
6.54%
|
|
Bradley, Allan
Wellcome Sanger Institute,
United Kingdom
2023 Rank: 33643
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 914 out of 138178 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33643 | 34925 |
| Total Cites | 2299 | 2483 |
| H-index | 22 | 24 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 41 | 44 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 969 | 994 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2009 | 2103 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.18 |
| Self-Citation Percentage |
7.41%
|
|
Bradley, Allan
Department of Medicine,
United Kingdom
2022 Rank: 31128
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 954 out of 127685 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31128 | 32457 |
| Total Cites | 2608 | 2803 |
| H-index | 24 | 25 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 42 | 47 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 1119 | 1154 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2270 | 2379 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.18 |
| Self-Citation Percentage |
6.96%
|
|
Bradley, Allan
Wellcome Sanger Institute,
United Kingdom
2021 Rank: 23359
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 759 out of 123644 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23359 | 25055 |
| Total Cites | 3995 | 4311 |
| H-index | 31 | 33 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 75 | 82 |
| Number of Single+First+Last Authored Papers | 156 | 156 |
| Total Cites to Single+First+Last Authored Papers | 1758 | 1827 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3455 | 3629 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
7.33%
|
|
Bradley, Allan
Wellcome Sanger Institute,
United Kingdom
2020 Rank: 22116
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Genetics & Heredity
Rank in SubField 1: 745 out of 105600 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22116 | 24344 |
| Total Cites | 3000 | 3241 |
| H-index | 28 | 28 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 51 | 55 |
| Number of Single+First+Last Authored Papers | 154 | 154 |
| Total Cites to Single+First+Last Authored Papers | 1401 | 1443 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2591 | 2733 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
7.44%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.